BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Degiuli M, Sasako M, Ponti A, Soldati T, Danese F, Calvo F. Morbidity and mortality after D2 gastrectomy for gastric cancer: results of the Italian Gastric Cancer Study Group prospective multicenter surgical study. J Clin Oncol 1998;16:1490-3. [PMID: 9552056 DOI: 10.1200/JCO.1998.16.4.1490] [Cited by in Crossref: 112] [Cited by in F6Publishing: 35] [Article Influence: 4.7] [Reference Citation Analysis]
Number Citing Articles
1 Topal B, Leys E, Ectors N, Aerts R, Penninckx F. Determinants of complications and adequacy of surgical resection in laparoscopic versus open total gastrectomy for adenocarcinoma. Surg Endosc 2008;22:980-4. [PMID: 17690934 DOI: 10.1007/s00464-007-9549-5] [Cited by in Crossref: 73] [Cited by in F6Publishing: 69] [Article Influence: 4.9] [Reference Citation Analysis]
2 Pedrazzani C, Marrelli D, Rampone B, De Stefano A, Corso G, Fotia G, Pinto E, Roviello F. Postoperative Complications and Functional Results After Subtotal Gastrectomy with Billroth II Reconstruction for Primary Gastric Cancer. Dig Dis Sci 2007;52:1757-63. [DOI: 10.1007/s10620-006-9655-6] [Cited by in Crossref: 39] [Cited by in F6Publishing: 24] [Article Influence: 2.6] [Reference Citation Analysis]
3 McCulloch P, Taylor I, Sasako M, Lovett B, Griffin D. Randomised trials in surgery: problems and possible solutions. BMJ. 2002;324:1448-1451. [PMID: 12065273 DOI: 10.1136/bmj.324.7351.1448] [Cited by in Crossref: 458] [Cited by in F6Publishing: 388] [Article Influence: 22.9] [Reference Citation Analysis]
4 Hu Y, Yoon SS. Extent of gastrectomy and lymphadenectomy for gastric adenocarcinoma. Surg Oncol 2021;40:101689. [PMID: 34839198 DOI: 10.1016/j.suronc.2021.101689] [Reference Citation Analysis]
5 Strong VE, Yoon SS. Extended lymphadenectomy in gastric cancer is debatable. World J Surg. 2013;37:1773-1777. [PMID: 23649527 DOI: 10.1007/s00268-013-2070-1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
6 Ito H, Inoue H, Ikeda H, Odaka N, Yoshida A, Satodate H, Onimaru M, Takayanagi D, Santi EG, Kudo SE. Surgical outcomes and clinicopathological characteristics of patients who underwent potentially noncurative endoscopic resection for gastric cancer: a report of a single-center experience. Gastroenterol Res Pract 2013;2013:427405. [PMID: 23762035 DOI: 10.1155/2013/427405] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
7 Blakely AM, Miner TJ. Surgical considerations in the treatment of gastric cancer. Gastroenterol Clin North Am. 2013;42:337-357. [PMID: 23639644 DOI: 10.1016/j.gtc.2013.01.010] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
8 Montgomery M, Fukuhara S, Karpeh M, Brower S. Evidence-based review of the management of early gastric cancer. Gastroenterol Rep (Oxf) 2013;1:105-12. [PMID: 24759815 DOI: 10.1093/gastro/got016] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
9 Tanizawa Y, Terashima M. Lymph node dissection in the resection of gastric cancer: review of existing evidence. Gastric Cancer. 2010;13:137-148. [PMID: 20820982 DOI: 10.1007/s10120-010-0560-5] [Cited by in Crossref: 40] [Cited by in F6Publishing: 43] [Article Influence: 3.3] [Reference Citation Analysis]
10 Tamura S, Takeno A, Miki H. Lymph node dissection in curative gastrectomy for advanced gastric cancer. Int J Surg Oncol. 2011;2011:748745. [PMID: 22312521 DOI: 10.1155/2011/748745] [Cited by in Crossref: 9] [Cited by in F6Publishing: 21] [Article Influence: 0.8] [Reference Citation Analysis]
11 Gong DJ, Miao CF, Bao Q, Jiang M, Zhang LF, Tong XT, Chen L. Risk factors for operative morbidity and mortality in gastric cancer patients undergoing total gastrectomy. World J Gastroenterol 2008; 14(42): 6560-6563 [PMID: 19030212 DOI: 10.3748/wjg.14.6560] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
12 Taki T, Hoya Y, Watanabe A, Nakayoshi T, Okamoto T, Sekine H, Mitsumori N, Yanaga K. Usefulness of chemoradiotherapy for inoperable gastric cancer. Ann R Coll Surg Engl 2017;99:332-6. [PMID: 27659357 DOI: 10.1308/rcsann.2016.0305] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
13 Souza FO, Pereira DV, Santos LH, Antunes L, Chiesa J. Gastric cancer patients treated by a general or gastric cancer surgical team: a comparative study. Arq Gastroenterol 2008;45:28-33. [PMID: 18425225 DOI: 10.1590/s0004-28032008000100006] [Reference Citation Analysis]
14 Kim MC, Jung GJ, Kim HH. Morbidity and mortality of laparoscopy-assisted gastrectomy with extraperigastric lymph node dissection for gastric cancer. Dig Dis Sci. 2007;52:543-548. [PMID: 17211711 DOI: 10.1007/s10620-006-9317-8] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 2.3] [Reference Citation Analysis]
15 Reddavid R, Sofia S, Chiaro P, Colli F, Trapani R, Esposito L, Solej M, Degiuli M. Neoadjuvant chemotherapy for gastric cancer. Is it a must or a fake? World J Gastroenterol 2018; 24(2): 274-289 [PMID: 29375213 DOI: 10.3748/wjg.v24.i2.274] [Cited by in CrossRef: 38] [Cited by in F6Publishing: 26] [Article Influence: 9.5] [Reference Citation Analysis]
16 Feng JF, Huang Y, Liu J, Liu H, Sheng HY, Wei WT, Lu WS, Chen DF, Chen WY, Zhou XM. Risk factors for No. 12p and No. 12b lymph node metastases in advanced gastric cancer in China. Ups J Med Sci. 2013;118:9-15. [PMID: 23039019 DOI: 10.3109/03009734.2012.729103] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
17 Maduekwe UN, Yoon SS. An evidence-based review of the surgical treatment of gastric adenocarcinoma. J Gastrointest Surg 2011;15:730-41. [PMID: 21399886 DOI: 10.1007/s11605-011-1477-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
18 Hur H, Lee HY, Lee HJ, Kim MC, Hyung WJ, Park YK, Kim W, Han SU. Efficacy of laparoscopic subtotal gastrectomy with D2 lymphadenectomy for locally advanced gastric cancer: the protocol of the KLASS-02 multicenter randomized controlled clinical trial. BMC Cancer 2015;15:355. [PMID: 25939684 DOI: 10.1186/s12885-015-1365-z] [Cited by in Crossref: 66] [Cited by in F6Publishing: 57] [Article Influence: 9.4] [Reference Citation Analysis]
19 Fugazzola P, Ansaloni L, Sartelli M, Catena F, Cicuttin E, Leandro G, De' Angelis GL, Gaiani F, Di Mario F, Tomasoni M, Coccolini F. Advanced gastric cancer: the value of surgery. Acta Biomed 2018;89:110-6. [PMID: 30561428 DOI: 10.23750/abm.v89i8-S.7897] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
20 Degiuli M, Sasako M, Ponti A, Calvo F. Survival results of a multicentre phase II study to evaluate D2 gastrectomy for gastric cancer. Br J Cancer 2004;90:1727-32. [PMID: 15150592 DOI: 10.1038/sj.bjc.6601761] [Cited by in Crossref: 131] [Cited by in F6Publishing: 126] [Article Influence: 7.3] [Reference Citation Analysis]
21 Maduekwe UN, Lauwers GY, Fernandez-Del-Castillo C, Berger DL, Ferguson CM, Rattner DW, Yoon SS. New metastatic lymph node ratio system reduces stage migration in patients undergoing D1 lymphadenectomy for gastric adenocarcinoma. Ann Surg Oncol. 2010;17:1267-1277. [PMID: 20099040 DOI: 10.1245/s10434-010-0914-6] [Cited by in Crossref: 42] [Cited by in F6Publishing: 44] [Article Influence: 3.5] [Reference Citation Analysis]
22 Schmidt B, Yoon SS. Varying lymphadenectomies for gastric adenocarcinoma in the East compared with the west: effect on outcomes. Am Soc Clin Oncol Educ Book 2012;:250-5. [PMID: 24451743 DOI: 10.14694/EdBook_AM.2012.32.28] [Reference Citation Analysis]
23 Harlow SP, Krag DN, Julian TB, Ashikaga T, Weaver DL, Feldman SA, Klimberg VS, Kusminsky R, Moffat FL Jr, Noyes RD, Beitsch PD. Prerandomization Surgical Training for the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-32 trial: a randomized phase III clinical trial to compare sentinel node resection to conventional axillary dissection in clinically node-negative breast cancer. Ann Surg 2005;241:48-54. [PMID: 15621990 DOI: 10.1097/01.sla.0000149429.39656.94] [Cited by in Crossref: 65] [Cited by in F6Publishing: 58] [Article Influence: 3.8] [Reference Citation Analysis]
24 Blakely AM, Miner TJ. Surgical considerations in the treatment of gastric cancer. Gastroenterol Clin North Am. 2013;42:337-357. [PMID: 23639644 DOI: 10.1016/j.gtc.2013.01.010.surgical] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
25 Coccolini F, Montori G, Ceresoli M, Cima S, Valli MC, Nita GE, Heyer A, Catena F, Ansaloni L. Advanced gastric cancer: What we know and what we still have to learn. World J Gastroenterol 2016; 22(3): 1139-1159 [PMID: 26811653 DOI: 10.3748/wjg.v22.i3.1139] [Cited by in CrossRef: 29] [Cited by in F6Publishing: 31] [Article Influence: 4.8] [Reference Citation Analysis]
26 Kodera Y, Fujiwara M, Koike M, Nakao A. Chemotherapy as a component of multimodal therapy for gastric carcinoma. World J Gastroenterol 2006; 12(13): 2000-2005 [PMID: 16610047 DOI: 10.3748/wjg.v12.i13.2000] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
27 Shigematsu Y, Niwa T, Yamashita S, Taniguchi H, Kushima R, Katai H, Ito S, Tsukamoto T, Ichinose M, Ushijima T. Identification of a DNA methylation marker that detects the presence of lymph node metastases of gastric cancers. Oncol Lett 2012;4:268-74. [PMID: 22844368 DOI: 10.3892/ol.2012.708] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
28 Schmidt B, Yoon SS. D1 versus D2 lymphadenectomy for gastric cancer. J Surg Oncol. 2013;107:259-264. [PMID: 22513454 DOI: 10.1002/jso.23127] [Cited by in Crossref: 46] [Cited by in F6Publishing: 50] [Article Influence: 4.6] [Reference Citation Analysis]
29 Sasako M. Clinical trials of surgical treatment of malignant diseases. Int J Clin Oncol. 2005;10:165-170. [PMID: 15990963 DOI: 10.1007/s10147-005-0486-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
30 Badgwell B, Das P, Ajani J. Treatment of localized gastric and gastroesophageal adenocarcinoma: the role of accurate staging and preoperative therapy. J Hematol Oncol 2017;10:149. [PMID: 28810883 DOI: 10.1186/s13045-017-0517-9] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 3.8] [Reference Citation Analysis]
31 Degiuli M, De Manzoni G, Di Leo A, D’Ugo D, Galasso E, Marrelli D, Petrioli R, Polom K, Roviello F, Santullo F, Morino M. Gastric cancer: Current status of lymph node dissection. World J Gastroenterol 2016; 22(10): 2875-2893 [PMID: 26973384 DOI: 10.3748/wjg.v22.i10.2875] [Cited by in CrossRef: 57] [Cited by in F6Publishing: 52] [Article Influence: 9.5] [Reference Citation Analysis]
32 Boerner T, Piso P. Cytoreductive Surgery for Peritoneal Carcinomatosis from Gastric Cancer: Technical Details. J Clin Med 2021;10:5263. [PMID: 34830545 DOI: 10.3390/jcm10225263] [Reference Citation Analysis]
33 Degiuli M, Calvo F. Survival of early gastric cancer in a specialized European center. Which lymphadenectomy is necessary? World J Surg. 2006;30:2193-2203. [PMID: 17103096 DOI: 10.1007/s00268-006-0179-1] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [Reference Citation Analysis]
34 Lee KG, Lee HJ, Yang JY, Oh SY, Bard S, Suh YS, Kong SH, Yang HK. Risk factors associated with complication following gastrectomy for gastric cancer: retrospective analysis of prospectively collected data based on the Clavien-Dindo system. J Gastrointest Surg. 2014;18:1269-1277. [PMID: 24820136 DOI: 10.1007/s11605-014-2525-1] [Cited by in Crossref: 67] [Cited by in F6Publishing: 65] [Article Influence: 8.4] [Reference Citation Analysis]
35 Randle RW, Swords DS, Levine EA, Fino NF, Squires MH, Poultsides G, Fields RC, Bloomston M, Weber SM, Pawlik TM, Jin LX, Spolverato G, Schmidt C, Worhunsky D, Cho CS, Maithel SK, Votanopoulos KI. Optimal extent of lymphadenectomy for gastric adenocarcinoma: A 7-institution study of the U.S. gastric cancer collaborative. J Surg Oncol 2016;113:750-5. [PMID: 26996496 DOI: 10.1002/jso.24227] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
36 Krasniqi E, Pellicori S, Formica V. Emerging role of S-1 in gastric cancer. Indian J Med Paediatr Oncol 2015;36:219-28. [PMID: 26811591 DOI: 10.4103/0971-5851.171542] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
37 Bozzetti F, Marubini E, Bonfanti G, Miceli R, Piano C, Gennari L. Subtotal vs total gastrectomy for gastric cancer: five-year survival rates in a multicenter randomized Italian trial. Italian Gastrointestinal Tumor Study Group. Ann Surg. 1999;230:170-178. [PMID: 10450730 DOI: 10.1097/00000658-199908000-00006] [Cited by in Crossref: 268] [Cited by in F6Publishing: 209] [Article Influence: 11.7] [Reference Citation Analysis]
38 Chen T, Yan D, Zheng Z, Yang J, Dong XDE. Evolution in the surgical management of gastric cancer: is extended lymph node dissection back in vogue in the USA? World J Surg Oncol. 2017;15:135. [PMID: 28716043 DOI: 10.1186/s12957-017-1204-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
39 Song JX, Tu XH, Wang B, Lin C, Zhang ZZ, Lin LY, Wang L. "Fast track" rehabilitation after gastric cancer resection: experience with 80 consecutive cases. BMC Gastroenterol. 2014;14:147. [PMID: 25135360 DOI: 10.1186/1471-230x-14-147] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]